Bruker Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference

Wednesday, January 3, 2018 Corporate News
Email Print This Page Comment bookmark
Font : A-A+

BILLERICA, Mass., Jan. 2, 2018 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the

36th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Tony Mattacchione, Senior Vice
President and CFO will present on behalf of the company on Monday, January 8th, 2018 at 10:00 AM Pacific Time.  

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's web site at ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (NASDAQ: BRKR)

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.  Bruker's high-performance scientific instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.  In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nanoanalysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics.  For more information, please visit: www.bruker.com .

Contact:  Miroslava Minkova  Head of Investor Relations Bruker Corporation T: +1 (978) 663 – 3660, ext. 1479 miroslava.minkova@bruker.com   

Cision View original content:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300576613.html

SOURCE Bruker Corporation

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store